Information Provided By:
Fly News Breaks for January 22, 2020
AGN, ABBV
Jan 22, 2020 | 06:37 EDT
Wells Fargo analyst Jacob Hughes downgraded Allergan (AGN) to Equal Weight from Overweight with a $198 price target. The analyst sees limited upside potential to the AbbVie (ABBV) deal terms and expects the transaction to close in the Q1 of 2020.
News For AGN;ABBV From the Last 2 Days
There are no results for your query AGN;ABBV